Lygos
An industrial biotech company developing a commercial bioprocess for manufacturing bio-based malonic acid.
All edits by Maxx Chatsko
Lygos received $120k in seed funding from Y combinatorCombinator, FundersClub, Fifty Years, Brainchild Holdings, and 10xGroup.
Lygos Series A raised $13 million led by OS Fund and IA Ventures along with First Round Capital, Y Combinator's Continuity Fund, Fifty Years, Vast venturesVentures, and others.
Lygos
Lygos is a synthetic biology company using microbugs and other techniques to make specialized chemicals.
An industrial biotech company developing a commercial bioprocess for manufacturing bio-based malonic acid.
Lygos is an industrial biotechnology company developing a synthetic biology company using microbugs andcommercial otherbioprocess techniquesfor tomanufacturing makebio-based specializedmalonic chemicalsacid. The companyIt was founded in 2010 by Eric Steen, Jay Keasling, and Jeffrey Dietrich in Berkeley, California.
Lygos received support from the United States departmentDepartment of energyEnergy (DOE) for their work on microbial fermentation technology to produce malonic acid. The utilizationbioprocess will lower the environmental impact and cost of microbugs is intended to produce malonic acid, which is useful in manufacturing, at lower environmentalthe impactspecialty andchemical costcompared overto petrochemicalpetroleum-based production processes.
Find more companies like Lygos
